Skip to content Skip to navigation

SIGF Affiliated with ChEM-H

ChEM-H awards Stanford Interdisciplinary Graduate Fellowships (SIGFs) at the interface of chemistry, biology, and engineering.

The Stanford Interdisciplinary Graduate Fellowship (SIGF) Program is a competitive, university-wide program that awards three-year fellowships to outstanding doctoral students engaged in interdisciplinary research. Since 2008, two hundred students have received an SIGF. Three independent institutes under the Dean of Research: ChEM-HBio-X, and Stanford Neurosciences Institute, in conjunction with the Vice Provost for Graduate Education, are working together to award this year's graduate fellowships in the biosciences. Applications received will be considered for the SIGFs affiliated with ChEM-H, Bio-X-Bowes Fellowships, Bio-X SIGFs, and SIGFs affiliated with the Neurosciences Institute.

To Apply

Please check back in Winter 2019 for information about the next application cycle.

Past Awardees

2018 ChEM-H SIGF Recipient: Corleone Delaveris, Chemistry PhD Student

Corleone Delaveris

Corleone is a graduate student in the lab of Prof. Carolyn Bertozzi in the Department of Chemistry. He studies how the glycocalyx — the various sugars of glycoproteins and other glycoconjugates on the cell surface — participates in disease and how it can be engineered. He combines organic synthesis, polymer chemistry, and immunology to study and manipulate the complex network of glycan-based interactions. Specific projects include studying how influenza viral fusion is affected by bulky glycoproteins and developing glycan-based immunotherapies for cancer. 

 

2018 ChEM-H SIGF Honorary Fellow: Catherine Liou, Chemical Engineering PhD Student

Catherine Liou

Catherine is a graduate student advised by Professor Elizabeth Sattely in the Department of Chemical Engineering. She is interested in the roles that dietary plant molecules play in modulating human health and disease. While metabolites found in dietary plants have long been implicated in disease prevention, there is limited understanding about the specific mechanisms through which they interact with human physiology. Catherine is hoping to understand and quantitate these interactions using an approach that considers a controlled plant metabolome, a relevant food context, and the gut microbiome. 

 

2017 ChEM-H SIGF Recipient: Winston Becker, Biophysics PhD Student & MD Student (MSTP)

Winston Becker

Winston is pursuing his PhD in Biophysics in the lab of Professor Will Greenleaf where he studies functional RNAs and nucleic acid binding proteins. He applies high-throughput methods to make millions of biophysical measurements in parallel. Using these methods, he is interested in 1) probing the folding and catalysis of large functional RNAs to better understand how RNA can be used to form complex molecular machines and 2) examining the sequence specificity of RNA and DNA binding proteins. In addition to doing research, Winston is pursuing his MD through Stanford’s Medical Scientist Training Program (MSTP). 

 

2017 ChEM-H SIGF Recipient: Jackie Carozza, Chemistry PhD Student

Jackie Carozza

Jackie studies the innate immune system and its relevance to fighting cancer in Professor Lingyin Li’s lab in the Department of Biochemistry. In particular, she is interested in the regulation of cGAMP, a newly discovered second messenger signaling molecule that activates the innate immune response. She combines chemical biology, cell biology, and immunology to understand and manipulate innate immune activation by cGAMP. 

 

 

2016 ChEM-H SIGF Recipient: Anna Koster, Chemistry PhD Student

Anna Koster

Anna is co-advised by Prof. Justin Du Bois in the Department of Chemistry and Prof. Merritt Maduke in the Department of Molecular and Cellular Physiology, and splits her time between the two labs doing chemical synthesis and electrophysiology. Her project has recently evolved into studying CLC-2, which is the most abundant chloride channel expressed in the brain. She uses a combination of computational techniques, synthetic chemistry, and molecular biology to develop highly selective and potent small-molecule inhibitors of CLC-2 in order to better understand its physiological function.